Editorial Board Members from Cancers Featured in the 2023 Highly Cited Researchers List Published by Clarivate
Recently, ClarivateTM revealed its 2023 list of Highly Cited ResearchersTM—individuals at universities, research institutes, and commercial organizations.
The scientists who were selected for this year’s list of Highly Cited Researchers published highly cited papers in the 11-year period from January 2012 to December 2022, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals, representing just 1 in 1,000 researchers worldwide. This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. The list is truly global, spanning 67 countries or regions and spread across a diverse range of research sciences and social sciences.
According to our statistics, 30 members of the editorial board of Cancers (ISSN: 2072-6694) were selected for the list of Highly Cited Researchers by ClarivateTM in 2023. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields. The Cancers Editorial Office sincerely congratulates all elected editorial members and hopes that they continue to have an academically productive relationship with the journal.
| Researcher | Category | Affiliation |
| Kepp, Oliver | Immunology | Gustave Roussy, France |
| Madabhushi, Anant | Cross-Field | Case Western Reserve University, United States |
| Garbe, Claus | Clinical Medicine | Eberhard Karls University of Tubingen, Germany |
| Sternberg, Cora N. | Clinical Medicine | Azienda Ospedaliera San Camillo-Forlanini, Italy |
| Curigliano, Giuseppe | Clinical Medicine | University of Milano (UniMi), Italy |
| Melero, Ignacio | Clinical Medicine | Clinica Universidad de Navarra, Spain |
| Melenhorst, Jan Joseph | Cross-Field | University of Pennsylvania, United States |
| Cortes, Javier | Clinical Medicine | International Breast Cancer Center, Spain |
| Delord, Jean-Pierre | Cross-Field | UNICANCER, France |
| Blay, Jean-Yves | Clinical Medicine | Universite Claude Bernard Lyon 1, France |
| Barnholtz-Sloan, Jill S. | Neuroscience and Behavior | NIH National Cancer Institute (NCI), United States |
| Byrd, John C. | Clinical Medicine | Ohio State University, United States |
| Kirkwood, John M. | Cross-Field | University of Pittsburgh, United States |
| Cortes, Jorge | Clinical Medicine | UTMD Anderson Cancer Center, United States |
| Lu, Lu | Cross-Field | Fudan University, China Mainland |
| Demaria, Marco | Molecular Biology and Genetics | University of Groningen, Netherlands |
| Mandala, Mario | Clinical Medicine | ASST Papa Giovanni XXIII, Italy |
| Dimopoulos, Meletios-Athanasios | Clinical Medicine | National & Kapodistrian University of Athens, Greece |
| Mahmoudi, Morteza | Cross-Field | Michigan State University, United States |
| Ahn, Myung-Ju | Clinical Medicine | Sungkyunkwan University (SKKU), South Korea |
| Richardson, Paul G. | Clinical Medicine | Dana-Farber Cancer Institute, United States |
| Kurzrock, Razelle | Clinical Medicine | University of California San Diego, United States |
| Dummer, Reinhard | Clinical Medicine | University of Zurich, Switzerland |
| Soffietti, Riccardo | Cross-Field | A.O.U. Citta della Salute e della Scienza di Torino, Italy |
| Scolyer, Richard A. | Clinical Medicine | University of Sydney, Australia |
| Oudard, Stephane | Cross-Field | Université Paris Cité, France |
| Chan, Timothy A. | Molecular Biology and Genetics | Cleveland Clinic Foundation, United States |
| Gutzmer, Ralf | Clinical Medicine | Ruhr University Bochum, Germany |
| Kudo, Masatoshi | Clinical Medicine | Kindai University (Kinki University), Japan |
| Saad, Fred | Clinical Medicine | University of Montreal, Canada |